Editing Mifepristone (section)

====European Union====
Outside the United States, mifepristone is marketed and distributed by Exelgyn Laboratories under the brand name Mifegyne. It was approved for use in [[Abortion in France|France]] in 1988 (initial marketing in 1989), the [[Abortion in the United Kingdom|United Kingdom]] in 1991, [[Abortion in Sweden|Sweden]] in 1992, then [[Abortion in Austria|Austria]], [[Abortion in Belgium|Belgium]], [[Abortion in Denmark|Denmark]], [[Abortion in Finland|Finland]], [[Abortion in Germany|Germany]], [[Abortion in Greece|Greece]], [[Abortion in Luxembourg|Luxembourg]], [[Abortion in the Netherlands|the Netherlands]], [[Abortion in Spain|Spain]], and [[Abortion in Switzerland|Switzerland]] in 1999.<ref>{{cite journal | vauthors = Christin-Maitre S, Bouchard P, Spitz IM | title = Medical termination of pregnancy | journal = The New England Journal of Medicine | volume = 342 | issue = 13 | pages = 946–56 | date = March 2000 | pmid = 10738054 | doi = 10.1056/NEJM200003303421307 }}</ref> In 2000, it was approved in Norway, Russia and Ukraine. Serbia and Montenegro approved it in 2001,<ref>{{cite journal | vauthors = Stojnić J, Ljubić A, Jeremić K, Radunović N, Tulić I, Bosković V, Dukanac J | title = [Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro] | journal = Vojnosanitetski Pregled | volume = 63 | issue = 6 | pages = 558–63 | date = June 2006 | pmid = 16796021 | doi = 10.2298/VSP0606558S | doi-access = free | title-link = doi }}</ref> [[Abortion in Belarus|Belarus]] and [[Abortion in Latvia|Latvia]] in 2002, [[Abortion in Estonia|Estonia]] in 2003, [[Abortion in Moldova|Moldova]] in 2004, [[Abortion in Albania|Albania]] and [[Abortion in Hungary|Hungary]] in 2005, [[Abortion in Portugal|Portugal]] in 2007, [[Abortion in Romania|Romania]] in 2008,<ref name="Gynuity 2009"/> [[Abortion in Bulgaria|Bulgaria]], [[Abortion in the Czech Republic|Czech Republic]] and [[Abortion in Slovenia|Slovenia]] in 2013.<ref>{{Cite web |url=http://gynuity.org/resources/read/llist-of-mifepristone-approval-en/ |title=List of Mifepristone Approvals | work = Gynuity Health Projects | date = March 2017 |access-date=28 September 2017 |archive-url= https://web.archive.org/web/20170926164348/http://gynuity.org/resources/read/llist-of-mifepristone-approval-en |archive-date=26 September 2017 |url-status=dead }}</ref> In [[Abortion in Italy|Italy]], clinical trials have been constrained by protocols requiring women be hospitalized for three days, but the drug was finally approved on 30 July 2009 (officialized later in the year), despite strong opposition from the Vatican. In Italy, the pill must be prescribed and used in a clinical structure and is not sold at chemists.<ref>{{cite news |date=31 July 2009 |title=Abortion pill approved in Italy |url=http://news.bbc.co.uk/1/hi/world/europe/8178152.stm |work=BBC News |access-date=31 July 2009 |archive-date=8 September 2017 |archive-url=https://web.archive.org/web/20170908184336/http://news.bbc.co.uk/1/hi/world/europe/8178152.stm |url-status=live }}</ref> It was approved in Hungary in 2005, but as of 2005 had not been released on the market yet, and was the target of protests.<ref>{{cite news|title=Abortion pill sparks bitter protest|newspaper=The Budapest Times|date=19 September 2005|access-date=16 September 2006|url=http://www.budapesttimes.hu/index.php?art=1077|url-status=live|archive-url=https://web.archive.org/web/20070111100214/http://www.budapesttimes.hu/index.php?art=1077|archive-date=11 January 2007}}</ref> Mifepristone is licensed in [[Abortion in the Republic of Ireland|Ireland]] for use of abortions up to 12 weeks since it was legalised in 2018.<ref>{{Cite web |url=https://www.hse.ie/eng/staff/pcrs/circulars/pharmacy/pharmacy-circular-040-2018.pdf | vauthors = Hoey AM |title= Medicines for Termination of Pregnancy Services | work = Health Service Executive. Primary Care Reimbursement Service | location = Dublin, Ireland | date = 20 December 2018 |access-date=28 June 2022 |archive-date=2 April 2022 |archive-url= https://web.archive.org/web/20220402045614/https://www.hse.ie/eng/staff/pcrs/circulars/pharmacy/pharmacy-circular-040-2018.pdf |url-status=live }}</ref> Mifepristone is not available in [[Abortion in Poland|Poland]], where abortion is highly restricted.<ref>{{cite news| vauthors = Green PS |title=A Rocky Landfall for a Dutch Abortion Boat|newspaper=The New York Times|date=24 June 2003|access-date=16 September 2006|url=https://query.nytimes.com/gst/fullpage.html?sec=health&res=9F02E3D7153BF937A15755C0A9659C8B63|url-status=live|archive-url=https://web.archive.org/web/20070210071338/http://query.nytimes.com/gst/fullpage.html?sec=health|archive-date=10 February 2007}}</ref>

Mifepristone 200&nbsp;mg tablets (Mifegyne, Mifepristone Linepharma, Medabon) have marketing authorizations in the [[European Economic Area]] from the [[European Medicines Agency]] (EMA) for:<ref name="Mifegyne SPC 2015"/><ref name="Mifepristone Linepharma SPC 2014">{{cite web|author=Linepharma|date=7 November 2014|title=Mifepristone Linepharma Summary of Product Characteristics (SPC)|location=London|publisher=Medicines and Healthcare Products Regulatory Agency (MHRA)|url=http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1452842392219.pdf|access-date=14 April 2016|url-status=dead|archive-url=https://web.archive.org/web/20160602234626/http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1452842392219.pdf|archive-date=2 June 2016}}</ref><ref name="Medabon SPC 2015">{{cite web|author=Sun Pharmaceuticals|date=4 March 2015|title=Medabon Summary of Product Characteristics (SPC)|location=London|publisher=Medicines and Healthcare Products Regulatory Agency (MHRA)|url=http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1454653236118.pdf|access-date=4 April 2016|url-status=dead|archive-url=https://web.archive.org/web/20160603014327/http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1454653236118.pdf|archive-date=3 June 2016}}</ref>
* Early first trimester medication abortion when followed by a prostaglandin analog (misoprostol or gemeprost) through 63 days gestational age
* Second trimester medication abortion when followed by a prostaglandin analog
* [[Cervical dilation|Cervical softening and dilation]] prior to first trimester [[abortion#Surgical|surgical abortion]]
* [[Labor induction|Induction of labor]] after fetal death in utero when prostaglandin analogs and [[oxytocin]] are contraindicated